Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 23 Similar Profiles
Neoplasms Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Model Mathematics
Fever Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2017

A phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms, and chronic myelomonocytic leukemia

Pratz, K. W., Rudek, M. A., Gojo, I., Litzow, M. R., McDevitt, M. A., Ji, J., Karnitz, L. M., Herman, J. G., Kinders, R. J., Smith, B. D., Gore, S. D., Carraway, H. E., Showel, M. M., Gladstone, D. E., Levis, M. J., Tsai, H. L., Rosner, G., Chen, A., Kaufmann, S. H. & Karp, J. E. Feb 15 2017 In : Clinical Cancer Research. 23, 4, p. 899-907 9 p.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Graft vs Host Disease
Bone Marrow

Individualized Molecular Analyses Guide Efforts (IMAGE): A prospective study of molecular profiling of tissue and blood in metastatic triple-negative breast cancer

Parsons, H. A. , Beaver, J. A. , Cimino-Mathews, A. , Ali, S. M. , Axilbund, J. , Chu, D. , Connolly, R. M. , Cochran, R. L. , Croessmann, S. , Clark, T. A. , Gocke, C. D. , Jeter, S. C. , Kennedy, M. R. , Lauring, J. , Lee, J. , Lipson, D. , Miller, V. A. , Otto, G. A. , Rosner, G. L. , Ross, J. S. & 10 others Slater, S., Stephens, P. J., Vandenberg, D. A., Wolff, A. C., Young, L. E., Zabransky, D. J., Zhang, Z., Zorzi, J., Stearns, V. & Park, B. H. Jan 15 2017 In : Clinical Cancer Research. 23, 2, p. 379-386 8 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Prospective Studies
Cranial Irradiation
Small Cell Lung Carcinoma
Prospective Studies

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

Shroff, R. T., Yarchoan, M., O'Connor, A., Gallagher, D., Zahurak, M. L., Rosner, G., Ohaji, C., Sartorius-Mergenthaler, S., Subbiah, V., Zinner, R. & Azad, N. S. May 23 2017 In : British Journal of Cancer. 116, 11, p. 1402-1407 6 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor
Mitogen-Activated Protein Kinase Kinases
Protein-Tyrosine Kinases
Disease-Free Survival